Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia

Table 2 Mean baseline and fourth year CD4 ⁺ and CD8 ⁺ cell count of pre-ART subjects

Cells/μl	Year	HIV/HCV co-infected (G4) (n = 9) Mean ± SD	HIV mono-infected (G3) (n = 9) Mean ± SD	p value
CD4⁺	1^st year	303 ± 73	435 ± 52	P < 0.003
CD4⁺	4^th year	211 ± 163	314 ± 27	P < 0.004
CD8⁺	1^st year	1612 ± 380	1676 ± 343	N/S
	4^th year	772 ± 552	1092 ± 177	P < 0.002

(Number of patients in parenthesis), N/S- not significant.
Key: G = Group, HAART = highly active antiretroviral therapy, ART = Antiretroviral treatment, μl = microliter, CD = Cluster designation/differentiation, SD = standard deviation.

ISSN: 1471-2172